Wednesday, December 15, 2021

Merck's COVID Drug May Cause Mutated DNA, Birth Defects, Cancer, And Reduced Male Fertility, NYT Reports



Merck’s newly FDA-approved COVID-19 antiviral drug, molnupiravir, may pose severe health consequences despite being purchased in bulk by the Biden administration prior to its approval.

ORIGINAL LINK